The systemic IgG response to Helicobacter pylori was examined in 70 pa
tients with gastric cancer. H pylori IgG antibodies were assayed by en
zyme linked immunosorbent assay (ELISA), and serological recognition o
f H pylori antigens was characterised by western blotting. A percentag
e of 78.5 were seropositive by ELISA. Two of five patients under age 5
0 were seronegative. Positivity was unrelated to age, sex, tumour type
, or site. Ninety one per cent of ELISA positive cancer patients recog
nised the H pylori cytotoxin associated 120 kilodalton (kD) protein, s
ignificantly more than a control group of 47 ELISA positive patients w
ith non-ulcer dyspepsia (72%). Four of 15 ELISA negative cancer patien
ts also showed recognition of this protein in western blots. Mucosal I
gA responses to H pylori were examined by immunoblotting supernatants
of in vitro cultured resected antral mucosa in an overlapping group of
19 gastric cancer patients. Eighteen had a positive response, includi
ng 10 of 11 negative for H pylori by biopsy urease testing. The system
ic and local immunoblotting results show that the high seroprevalence
of H pylori antibodies detected by ELISA is nevertheless an underestim
ate of past infection. Dyspepsia screening policies based solely on H
pylori ELISA would miss some young patients with gastric cancer. Furth
er study of the relation of the H pylori cytotoxin to gastric precance
rous lesions is warranted.